** Shares of Australia's Saluda Medical SLD.AX fall as
much as 17.9% to a record low of A$0.275
** Stock on track for its weakest session since August 28,
if trends hold
** The medical device maker initiates a voluntary field
action for certain Evoke Closed Loop Stimulator devices
following identification of a low-incidence issue linked to a
third-party manufacturing process change
** Evoke Closed Loop Stimulator is an implanted spinal cord
stimulation system
** Company says devices manufactured after implementation of
corrective actions are unaffected by the issue
** Saluda says it does not expect the field action to
disrupt product supply or its ability to meet customer demand
** Company is engaging with the US FDA and other regulators
regarding the action and its classification
** YTD, stock down 77.9%, including the session's moves
(Reporting by Paridhi Minda in Bengaluru)
((Paridhi.minda@thomsonreuters.com;))